Envista Holdings Corporation (NVST) News
Follow Envista Holdings Corporation (NVST) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Envista Reports Higher Fiscal Q3 Adjusted Earnings and Revenue, Raises 2026 EPS Outlook
Envista reported higher fiscal third-quarter adjusted earnings and revenue and raised its 2026 adjusted EPS outlook.
EQUITY | Nov 05, 2026, 08:21 AM UTC
M
Envista Reports Q3 Sales of $691.5 Million
Q3 sales were $691.5 million, versus an IBES estimate of $688.7 million. Reuters also reported net income of $508 million.
EARNINGS | Nov 04, 2026, 09:11 PM UTC
M
Envista Raises Full-Year 2026 Earnings Guidance
Envista raised its full-year 2026 earnings guidance. Q3 included a $428 million operating profit and a $2.62 diluted EPS foreign-currency translation gain before tax effects; the gain had no cash impact and did not affec
EQUITY | Nov 04, 2026, 09:06 PM UTC
L
Envista Holdings Reports Third-Quarter EPS of $3.11
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Envista Holdings Reports Third-Quarter Net of $508.3 Million
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Envista Holdings Reports Third-Quarter Adjusted EPS
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Envista Schedules Q3 2026 Earnings Call
Envista has scheduled its third quarter 2026 earnings call.
EQUITY | Oct 06, 2026, 08:15 PM UTC
L
Envista Holdings Price Target Cut to $26.00/Share From $29.00 by BMO Capital
Ratings actions from Benzinga: GMT) Envista Holdings Is Maintained at Market Perform by BMO CapitalRatings actions from Benzinga
NEWS | Sep 28, 2026, 04:29 PM UTC
H
NVST: Dental markets recover, China VBP impacts short-term, but long-term growth outlook is positive
Dental and equipment markets are rebounding post-COVID, with consumables and diagnostics leading growth, especially in North America. China’s VBP policy is causing short-term revenue softness but is expected to benefit h
EARNINGS | Sep 15, 2026, 03:15 PM UTC
L
NVST: North America drives growth while China VBP shifts revenue timing but strengthens long-term position
Leadership highlighted strong execution and market share gains, especially in North America, with diagnostics and consumables leading growth. China’s VBP policy is causing short-term revenue shifts but is expected to str
EARNINGS | Sep 15, 2026, 02:49 PM UTC
L
NVST - Envista Announces Participation in Baird 2026 Global Healthcare Conference
NVST - Envista Announces Participation in Baird 2026 Global Healthcare Conference
EQUITY | Sep 08, 2026, 08:10 PM UTC
L
JP Morgan raises Envista to Overweight from Neutral
JP Morgan upgraded Envista Holdings to Overweight from Neutral.
EQUITY | Sep 03, 2026, 09:12 PM UTC
L
Envista Holdings Raises FY2026 Adj EPS Guidance from $1.35-$1.45 to $1.50-$1.55 vs $1.43 Est
Envista Holdings (NYSE: NVST ) raises FY2026 Adj EPS guidance from $1.35-$1.45 to $1.50-$1.55 vs $1.43 analyst estimate..
EARNINGS | Aug 05, 2026, 08:27 PM UTC
L
NVST - Envista Reports Second Quarter 2026 Results
NVST - Envista Reports Second Quarter 2026 Results
EARNINGS | Aug 05, 2026, 08:06 PM UTC
L
NVST - Envista to Host Investor Day on September 17, 2026
NVST - Envista to Host Investor Day on September 17, 2026
EQUITY | Jul 28, 2026, 08:16 PM UTC